Effective Cancer Genotyping-Many Means to One End.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31138589.
- Also identified by DOI 10.1158/1078-0432.CCR-19-1233 and PMC identifier 6679798.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Precision cancer medicine requires effective genotyping of every patient's tumor to optimally design treatment plans. Despite its imperfect sensitivity, the rapidity and convenience of cell-free DNA sequencing makes it an essential complement to tumor genotyping, which, when used appropriately, can aid the pursuit of effective genotyping for all patients.<i>See related article by Leighl et al., p. 4691</i>.
Medical subject headings
- Neoplasms